Literature DB >> 3920145

Effects of HC 20-511 (ketotifen) on chemiluminescence of human neutrophils.

T Kato, T Terui, H Tagami.   

Abstract

The effects of ketotifen on the chemiluminescence (CL) and chemotaxis of human neutrophils were studied in vitro. Stimulations of neutrophils by concanavalin A (Con A), calcium ionophore A23187 (CI) and formyl-methionyl-leucyl-phenylalanine (FMLP) were strongly suppressed in contrast with that by zymosan, which was only slightly inhibited in CL assay; the inhibitory effect of ketotifen was dose dependent. The addition of ketotifen even after stimulations of CI' and FMLP also inhibited CL response. The neutrophils which were activated by incubation with FMLP (10(-7)M) at 37 degrees C for 60 min emitted much greater light in CI-induced CL assay than those without the pretreatment with FMLP. Such enhanced CL of activated cells was also markedly suppressed by ketotifen. On the other hand, ketotifen did not show any inhibitory effect on the direct movement of neutrophils by FMLP (10(-7)M) at the concentrations which inhibited CL responses. These unique pharmacological activities of ketotifen are encouraging for its potential clinical usage as an antiinflammatory agent in some disorders associated with neutrophils as well as for its experimental usefulness for the analysis of various functions of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920145     DOI: 10.1007/bf00915411

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  12 in total

1.  Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug, HC 20-511 (ketotifen).

Authors:  H Tomioka; S Yoshida; M Tanaka; A Kumagai
Journal:  Monogr Allergy       Date:  1979

2.  The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.

Authors:  U Martin; D Römer
Journal:  Arzneimittelforschung       Date:  1978

3.  Measurement of chemiluminescence in freshly drawn human blood. I. Role of granulocytes, platelets, and plasma factors in zymosan-induced chemiluminescence.

Authors:  T Kato; H Wokalek; E Schöpf; H Eggert; M Ernst; E T Rietschel; H Fischer
Journal:  Klin Wochenschr       Date:  1981-03-02

4.  Phagocyte-produced free radicals: roles in cytotoxicity and inflammation.

Authors:  J M McCord; K Wong
Journal:  Ciba Found Symp       Date:  1978 Jun 6-8

5.  Influence of phenylbutazone on leukocyte chemiluminescence and function.

Authors:  C O Solberg; C D Allred; H R Hill
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-08

6.  Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.

Authors:  D E Van Epps; M L Garcia
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

7.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Monocyte dependent excited oxygen radical generation in rheumatoid arthritis: inhibition by gold sodium thiomalate.

Authors:  M Harth; P A Keown; J F Orange
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

9.  Hydroxyl radical scavengers produce similar decreases in the chemiluminescence responses and bactericidal activities of neutrophils.

Authors:  J E Repine; K S Johansen; E M Berger
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of psoriatic scale extracts on oxidative metabolic responses in granulocytes assessed by chemiluminescence.

Authors:  T Kato; T Terui; H Takematsu; H Tagami
Journal:  Inflammation       Date:  1989-02       Impact factor: 4.092

Review 2.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.